HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Master Thesis

Ophtalmie sympathique : suivi au long-cours

Abstract : Objective: to evaluate retrospectively the long-term visual outcome and steroid-sparing related to successive steps of the medico-surgical management of sympathetic ophthalmia (SO). Methods: medical records of patients with SO, followed in a reference center for rare diseases, for at least 3 years, were reviewed for history of ocular trauma or surgery and subsequent development of SO, presenting symptoms, treatments, and visual outcomes. Results: Ten patients fitted the inclusion criteria. The median time of SO occurrence was 1,5 years. At admission, median best-corrected visual acuity (BCVA) was 0,45 LogMAR [0,2;0,65], median steroid dependence daily dose was 40 mg [30;65], and inflammatory macular edema was present in 7/10 eyes. The median time of follow up was 14 years [6,5;25]. At the end of follow-up, there were no significative improvement for the BCVA with a median of 0,4 LogMAR [0,1;0,75] p=0,87. However, the median daily prednisone dose was significantly decreased to 8 mg [3,5;12,5] p<0,01. At six months on prednisone associated to immunosuppressive drugs, inflammation and macular edema control was assessed using antimetabolites in 4/6 treatments, anti TNF-alpha in 0/3 treatments, cyclophosphamide in 0/1 treatment, cyclosporine in 0/1 treatment, interferon-α-2a in 6/6 treatments, polyvalent immunoglobulin in 0/1 treatment, enucleation in 0/3 treatments. Conclusion: Interferon-α-2a and antimetabolites seemed to be useful in case of macular edema and in steroid sparing unlike enucleation which appeared to be pejorative in uveitis course in that small series.
Document type :
Master Thesis
Complete list of metadata

Contributor : Pointe à Pitre Bhu Connect in order to contact the contributor
Submitted on : Thursday, September 16, 2021 - 3:47:56 PM
Last modification on : Thursday, February 17, 2022 - 5:53:13 PM


Files produced by the author(s)


  • HAL Id : dumas-03346753, version 1



Beverly Casalan. Ophtalmie sympathique : suivi au long-cours. Organes des sens. 2020. ⟨dumas-03346753⟩



Record views


Files downloads